MedTrace Logo

Pilot Study of ZetaFuse™ Bone Graft for the Treatment of Cervical Degenerative Disc Disease

NCT05971329 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-04-24

No results posted yet for this study

Summary

The goal of this pilot clinical trial is to test the safety and preliminary performance of the ZetaFuse Bone Graft in patient requiring fusion of the C3-C7 vertebral bones due to pain or loss of neurological function.

Participants will be treated with ZetaFuse during surgical intervention to reduce pain and the loss of neurological function.

Conditions

  • Radiculopathy, Cervical
  • Myelopathy Cervical
  • Neurological Abnormality
  • Disc Disease
  • Disc Degeneration

Interventions

DEVICE

Cervical Fusion (ZetaFuse™ Bone Graft)

Fusion of the C3-C7 cervical vertebral bodies

Sponsors & Collaborators

  • Zetagen Therapeutics, Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2026-09-30
Completion
2027-09-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05971329 on ClinicalTrials.gov